No Data
Express News | China Vice Premier, to Foreign Business Leaders: China Will Continue to Improve Business Environment and Welcome More Investment by Multinational Companies in - Commerce Ministry
Is Eli Lilly and Company (LLY) The Best Robinhood Stock to Buy According to Analysts?
Express News | China Vice Premier He Lifeng Met With Heads of Apple, Pfizer, Mastercard, Eli Lilly, Cargill and Others at Business Forum on Sunday - Commerce Ministry
'Zepbound Copycats Remain Online Despite FDA Ban' - CNBC
Eli Lilly and Co's weight loss drug Mounjaro has been launched in India, causing Novo-Nordisk A/S to drop in pre-market trading.
Eli Lilly and Co officially launched its best-selling diabetes and weight-loss drug Mounjaro in India on Thursday, ahead of its main competitor Novo-Nordisk A/S in this Global most populous country.
Express News | China's Commerce Minister: Hopes Foreign-Funded Enterprises Will Overcome Uncertain Impact of External Environment, Continue to Deepen Business in Chinese Market
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Junius Falcon : Buy when back to 720 or even 650. EPS up 70% YoY by 2025, will end up P/E 30+y, but only little growth in 2026, so it would go sideway in mid term.
LLY is diversified drugs, it is safer. NVO needs new drugs than weight loss. If they get out competed in that they are done. Its current EPS growth does support its current P/E